Drugs / Acetylsalicylic Acid
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01847417 | May → Jul 2013 | peptic ulcer disease | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Acetylsalicylic Acid | “Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of Acetylsalicylic Acid (ASA) and Pantoprazole (Each Capsule Contains ASA 100 mg and...” NCT01847417 ↗ |
| Known as | ASA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01847417 ↗ |